Trial Profile
A retrospective, observational study of tenofovir disoproxil fumarate in patients with HIV-1 infection
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 02 Dec 2015
Price :
$35
*
At a glance
- Drugs Tenofovir disoproxil fumarate (Primary) ; Antiretrovirals
- Indications HIV-1 infections
- Focus Adverse reactions
- 02 Dec 2015 New trial record